Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/07/2019 | 05:55am EDT

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Correction notification: Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

07.08.2019 / 11:51
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


- Share buy-back - 7th Interim Report (correction notification)

In the period from July 29, 2019 until and including August 2, 2019, a total of 63,746 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF):

XETRA

Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR

29/07/2019 26,119 67.6737
30/07/2019 34,871 64.3697
31/07/2019 - -
01/08/2019 - -
02/08/2019 - -
 

Chi-X Europe

Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR

29/07/2019 - -
30/07/2019 2,756 63.0920
31/07/2019 - -
01/08/2019 - -
02/08/2019 - -
 

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including August 2, 2019 therefore amounts to 1,534,327 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., August 5, 2019



07.08.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

853291  07.08.2019 

fncls.ssp?fn=show_t_gif&application_id=853291&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS MEDICAL CARE AG
09/19FRESENIUS MEDICAL CARE : Launches 4008A™ Dialysis Machine in China
BU
09/16FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
09/15Fresenius drops possible sale of blood transfusion unit - spokesman
RE
09/10FRESENIUS6CPRF : Fresenius Medical Care's annual medical report explores how Int..
AQ
09/09FRESENIUS MEDICAL CARE : annual medical report explores how Interconnected Intel..
PU
09/09FRESENIUS MEDICAL CARE : Spectra Laboratories - Fresenius Medical Care builds ne..
AQ
09/09FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
09/06FRESENIUS MEDICAL CARE : Builds New Laboratory in US
DJ
09/05Fresenius Medical Care to Invest in Its Stem-Cell Subsidiary Unicyte
DJ
09/03Fresenius Helios Acquires Two Hospitals in Colombia
DJ
More news
Financials (USD)
Sales 2019 19 393 M
EBIT 2019 2 592 M
Net income 2019 1 318 M
Debt 2019 9 019 M
Yield 2019 1,84%
P/E ratio 2019 16,0x
P/E ratio 2020 13,6x
EV / Sales2019 1,56x
EV / Sales2020 1,45x
Capitalization 21 148 M
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 87,26  $
Last Close Price 69,27  $
Spread / Highest target 59,7%
Spread / Average Target 26,0%
Spread / Lowest Target -29,6%
EPS Revisions
Managers
NameTitle
Rice Powell Chief Executive Officer
Dieter Schenk Chairman-Supervisory Board
Michael Brosnan Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
William P. Johnston Member-Supervisory Board